Research study Program year 2025 Source: CMS Open Payments

A Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study of Tezepelumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyposis WAYPOINT

Research payments

$2,125,888

158 payments

Through program year 2025, $2,125,888 in research payments was reported against A Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study of Tezepelumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyposis WAYPOINT, across 158 payments, paid by AstraZeneca Pharmaceuticals LP.

Paid by: AstraZeneca Pharmaceuticals LP
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$279,352	18
2024	Research	$266,898	42
2023	Research	$739,056	42
2022	Research	$625,327	34
2021	Research	$215,255	22

Breakdown

Who paid Research payments · program years 2021–2025

AstraZeneca Pharmaceuticals LP $2,125,888 158 payments

Who received the money Research payments · program years 2021–2025

Univ Of Missouri Health Care Teaching hospital · MO $225,580 9 payments
Colorado Allergy And Asthma Centers, Pc Organisation paid for research $214,641 9 payments
Allergy Asthma And Clinical Research Center Organisation paid for research $211,612 9 payments
Ent And Allergy Partners Organisation paid for research $160,942 5 payments
Chicago Ent Organisation paid for research $131,397 7 payments
Newportnativemd, Inc. Organisation paid for research $116,629 7 payments
Pharmaceuticals Research Consulting Inc. Organisation paid for research $105,295 5 payments
DaVinci Research, LLC Organisation paid for research $100,759 7 payments
Johns Hopkins University Organisation paid for research $93,494 4 payments
Piedmont Ear Nose And Throat Associates PA Organisation paid for research $87,731 7 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.